• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Bupivacaine and buprenorphine: Potential dynamic duo in veterinary dental nerve blocks

October 17, 2016
Michael Nappier, DVM, DABVP

When it comes to regional nerve blocks in veterinary dentistry, are two bupsbupivacaine and buprenorphinebetter than one?

Igor Normann/Shutterstock.comBupivacaine regional nerve blocks are commonly used to provide short- to medium-term analgesia in veterinary dentistry. Because human research has shown that adding buprenorphine to a nerve block can increase the analgesia duration threefold, the practice is becoming more popular in veterinary medicine. But until this study, its effectiveness in animals had not been formally investigated.

Study overview

Eight healthy adult beagles with a calculus stage of 0-1 and a gingivitis index of 0-1 were enrolled in the study. Using dental dolorimetry, a previously proven model of inducing pain through electrical conduction, the researchers were able to determine the baseline minimum alveolar concentration (MAC) for noxious stimulation of the right maxillary canine tooth. Next, each dog received a maxillary nerve block treatment on two separate occasions. One nerve block used bupivacaine alone, and the second block used a mixture of bupivacaine and buprenorphine. After every treatment, the researchers determined each dog's MAC and calculated its difference from the normal MAC. This continued on a daily basis until each participant's MAC matched the original baseline value.

Findings

The duration of analgesia for both bupivacaine alone and bupivacaine plus buprenorphine was longer than expected. With bupivacaine alone, all eight dogs showed significant MAC sparing effects for a duration of 24 hours. In some dogs, the effects lasted 72 hours. With both bupivacaine and buprenorphine, significant MAC sparing effects lasted for 48 hours in all dogs and 96 hours in some. Two of the eight dogs continued to demonstrate MAC sparing effects with the dual block at 96 hours but were not tested further.

Advertisement

Take home points

Both bupivacaine alone and a bupivacaine plus buprenorphine mix are effective at providing regional nerve blocks in veterinary dentistry, and the study suggests that the durations of analgesia for both blocks are likely significantly longer than previously suspected. The extended duration of the bupivacaine plus buprenorphine block was particularly interesting since 25% of the dogs saw an analgesia duration of at least four days. Because of the small sample size, the differences between the two regional blocks were not proven to be statistically significant. The study's researchers estimate that 40 dogs would be needed for the results to be statistically significant.

 

Link to abstract: http://jov.sagepub.com/content/33/2/90.abstract

Snyder LB, Snyder CJ, Hetzel S. Effects of buprenorphine added to bupivacaine infraorbital nerve blocks on isoflurane minimum alveolar concentration using a model for acute dental/oral surgical pain in dogs. J Vet Dent 2016;33(2):90-96.

Related Content:

Pain ManagementDentistryTechnicians
Veterinary tech students awarded national scholarship
Veterinary tech students awarded national scholarship
AAHA seeks applicants for its board, including for a newly created veterinary technician role
AAHA seeks applicants for its board, including for a newly created veterinary technician role
Targeting care for senior cats and their caretakers
Targeting care for senior cats and their caretakers

Advertisement

Latest News

Kentucky Humane Society with Louisville Metro Animal Services to host mega adoption event

San Diego Zoo celebrates Andean bear cub twins

Spring’s pet toxins have sprung

IBPSA and Zoundz Music for Pets team up to reduce pet anxiety in pet care facilities

View More Latest News
Advertisement